Patents by Inventor Fu-shin X. YU

Fu-shin X. YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220202701
    Abstract: The present disclosure describes compositions and methods to promote wound healing. The compositions and methods include an interleukin-1 beta (IL-1?) receptor antagonist (IL-1Ra), such as anakinra. The IL-1Ra can be administered topically to a chronic wound including a diabetic ulcer.
    Type: Application
    Filed: March 15, 2022
    Publication date: June 30, 2022
    Applicant: Wayne State University
    Inventor: Fu-Shin X. Yu
  • Publication number: 20200000711
    Abstract: The present disclosure describes compositions and methods to promote wound healing. The compositions and methods include an interleukin-1 beta (IL-1?) receptor antagonist (IL-1Ra), such as anakinra. The IL-1Ra can be administered topically to a chronic wound including a diabetic ulcer.
    Type: Application
    Filed: September 13, 2019
    Publication date: January 2, 2020
    Applicant: Wayne State University
    Inventor: Fu-Shin X. Yu
  • Patent number: 10478394
    Abstract: The present disclosure describes compositions and methods to promote wound healing. The compositions and methods include an interleukin-1 beta (IL-1B) receptor antagonist (IL-1Ra), such as anakinra.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: November 19, 2019
    Assignee: Wayne State University
    Inventor: Fu-Shin X. Yu
  • Publication number: 20180110726
    Abstract: The present disclosure describes compositions and methods to promote wound healing. The compositions and methods include an interleukin-1 beta (IL-1B) receptor antagonist (IL-1Ra), such as anakinra.
    Type: Application
    Filed: March 10, 2016
    Publication date: April 26, 2018
    Inventor: Fu-Shin X. Yu
  • Publication number: 20180028608
    Abstract: The present disclosure describes a genome-wide transcriptional analysis of differentially expressed genes in diabetic, non-diabetic, normal and wounded tissue. The analysis allowed development of compositions and methods to diagnose diabetes and/or to treat negative effects of diabetes, including delayed wound healing and reduced vision.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 1, 2018
    Inventor: Fu-Shin X. Yu
  • Patent number: 8889149
    Abstract: The disclosure describes use of flagellin polypeptides to induce tolerance to gram negative bacteria, such as Pseudomonas aeruginosa, in order to alleviate the effects of the inflammatory response to bacterial infection in a patient. Also described are methods and compositions for treating and preventing keratitis, cystic fibrosis, asthma, and other diseases and conditions in which inflammation contributes to the pathology and symptoms.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: November 18, 2014
    Assignee: Wayne State University
    Inventors: Fu-shin X. Yu, Ashok Kumar, Jing Zhang, Linda D. Hazlett, Jia Yin
  • Publication number: 20100104516
    Abstract: The disclosure describes use of flagellin polypeptides to induce tolerance to gram negative bacteria, such as Pseudomonas aeruginosa, in order to alleviate the effects of the inflammatory response to bacterial infection in a patient. Also described are methods and compositions for treating and preventing keratitis, cystic fibrosis, asthma, and other diseases and conditions in which inflammation contributes to the pathology and symptoms.
    Type: Application
    Filed: February 15, 2007
    Publication date: April 29, 2010
    Applicant: WAYNE STATE UNIVERSITY
    Inventors: Fu-shin X. YU, Ashok KUMAR, Jing ZHANG, Linda D. HAZLETT, Jia YIN